Description Range Cancer Therapeutics ETF
CNCR ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅Ρ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ ΠΊ ΠΎΡ Π²Π°ΡΡ Π½ΠΈΡΠΈ Π² ΡΠ΅ΠΊΡΠΎΡΠ΅ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ ΡΠ°Π½Π΅Π½ΠΈΡ. ΠΠ½ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°Π΅Ρ ΡΠ°Π²Π½ΠΎΠ²Π·Π²Π΅ΡΠ΅Π½Π½ΠΎΠ΅ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΠΏΡΠΈΠΌΠ΅ΡΠ½ΠΎ Π½Π° 30 ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΡΠ°Π·ΠΌΠ΅ΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΎΠ΄ΠΎΠ±ΡΠΈΠ»ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΠ°ΠΊΠΎΠ²ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ Π½Π° ΡΡΠ½ΠΊΠ°Ρ Π‘Π¨Π ΠΈΠ»ΠΈ ΠΠ²ΡΠΎΠΏΡ ΠΈΠ»ΠΈ ΠΊΠΎΡΠΎΡΡΠ΅ ΡΡΠ°ΡΡΠ²ΡΡΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΈΡΠΏΡΡΠ°Π½ΠΈΡΡ ΡΠ°ΠΊΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π½Π° Π»ΡΠ΄ΡΡ . Π€ΠΎΠ½Π΄ ΡΡΡΠ΅ΠΌΠΈΡΡΡ ΠΏΠΎΠ»ΡΡΠΈΡΡ ΡΠ΅Π»ΠΎΡΡΠ½ΠΎΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ ΠΎ ΠΏΡΠΎΡΡΡΠ°Π½ΡΡΠ²Π΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ, Π²ΠΊΠ»ΡΡΠ°Ρ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ ΠΏΡΠΈΠ΅ΠΌΠ° Π»Π΅ΠΊΠ°ΡΡΡΠ². Π Π°Π²Π½ΡΠΉ Π²Π΅Ρ ΡΠ΅Π½Π½ΡΡ Π±ΡΠΌΠ°Π³ ΠΏΡΠΈΠ²Π»Π΅ΠΊΠ°Π΅Ρ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΊ Π±ΠΎΠ»Π΅Π΅ ΠΌΠ΅Π»ΠΊΠΈΠΌ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΡΠΌ, Ρ ΠΊΠΎΡΠΎΡΡΡ Π΅ΡΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π΄Π»Ρ ΡΠΎΡΡΠ°.
More details| 10 Π»Π΅ΡΠ½ΡΡ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 0 |
|---|---|
| 3 Π»Π΅ΡΠ½ΡΡ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | -45.97 |
| 5 Π»Π΅ΡΠ½ΡΡ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | -19.22 |
| Assets class size | Multi-Cap |
| Country | USA |
| Country ISO | US |
| Focus | Health Care |
| ISIN | US26922A8264 |
| Issuer | Range Cancer |
| P/BV | 2.7 |
| P/S | 5.08 |
| Region specific | Broad |
| Segment | Equity: Global Pharma, Biotech & Life Sciences |
| Strategy | Equal |
| ΠΠ΅ΡΠ° | 1.12 |
| ΠΠ°Π»ΡΡΠ° | usd |
| ΠΠΎΠ΄ΠΎΠ²Π°Ρ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 47.24 |
| ΠΠ°ΡΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΡ | 2015-10-13 |
| ΠΠΈΠ² Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 0.1196 |
| ΠΠ½Π΄Π΅ΠΊΡ | Range Oncology Therapeutics Index |
| ΠΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ | 72 |
| ΠΠΎΠΌΠΈΡΡΠΈΡ | 0.79 |
| ΠΠΎΠ»Π½ΠΎΠ΅ Π½Π°ΠΈΠΌΠ΅Π½ΠΎΠ²Π°Π½ΠΈΠ΅ | Range Cancer Therapeutics ETF |
| Π Π΅Π³ΠΈΠΎΠ½ | United States |
| Π‘Π°ΠΉΡ | link |
| Π‘ΡΠ΅Π΄Π½ΠΈΠΉ P/E | 22.2 |
| Π’ΠΈΠΏ Π°ΠΊΡΠΈΠ²Π° | Equity |
| Π’ΠΎΠΏ 10 ΡΠΌΠΈΡΠ΅Π½ΡΠΎΠ², % | 40.88 |
| Change price per day: | +0.3627% (11.055) |
|---|---|
| Change price per week: | -2.55% (11.385) |
| Change price per month: | -13.39% (12.81) |
| Change price per 3 month: | -21.09% (14.06) |
| Change price per half year: | -25.83% (14.96) |
| Change price per year to date: | -12.33% (12.656) |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
| Title | Industry | Share, % | P/BV | P/S | P/E | EV/Ebitda | Dividend yield |
|---|---|---|---|---|---|---|---|
 Summit Therapeutics Inc. |
Healthcare | 7.06601 | 18.9 | 790.91 | 0 | -17.14 | 0 |
 Geron Corporation |
Healthcare | 3.52974 | 5.27 | 5513.83 | 0 | -6.85 | 0 |
| Enliven Therapeutics, Inc. | Healthcare | 2.57735 | 2.09 | 0 | 285.84 | -4.99 | 0 |
 Nurix Therapeutics, Inc. |
Healthcare | 2.40875 | 2.78 | 26.81 | 0 | -6.48 | 0 |
 IGM Biosciences, Inc. |
Healthcare | 2.23113 | 2.19 | 208.76 | 10.26 | -1.46 | 0 |
 Foghorn Therapeutics Inc. |
Healthcare | 2.15956 | -3.61 | 8.16 | 0 | -2.45 | 0 |
| Acrivon Therapeutics, Inc. | Healthcare | 2.03779 | 0.9109 | 0 | 0 | -1.18 | 0 |
| Erasca, Inc. | Healthcare | 1.89878 | 1.03 | 0 | 0 | -2.1 | 0 |
 Revolution Medicines, Inc. |
Healthcare | 1.88416 | 1.79 | 282.39 | 0 | -5.57 | 0 |
| Nuvation Bio Inc. | Healthcare | 1.80964 | 0.539 | -421.42 | 0 | -2.89 | 0 |
| 27.61 | 3.19 | 640.94 | 29.61 | -5.11 | 0.00000 |
